Health  Vol.6 No.12 , June 2014
Statins as a Candidate of Drugs for Intracranial Aneurysm Treatment
Abstract: The treatment for intracranial aneurysm (IA) is socially important because of poor outcome posed by subarachnoid hemorrhage after rupture. Further, the incidence of IAs in general public is high and, indeed, in developed countries many IAs are incidentally found through brain check. However, to date, options for treatment of IAs to prevent rupture are quite limited only to surgical procedures such as microsurgical clipping and endovascular coiling. Taking into account unavoidable risks of complication from surgical interventions and numerous aneurysm careers without treatment, less invasive medical therapies should be established. In human IA lesions, the presence of inflammatory responses, such as expressions of pro-inflammatory mediators and infiltration of inflammatory cells, have been reported, which suggests the involvement of inflammatory responses in the pathogenesis of IA. Recent experimental studies using rodent models have revealed the crucial role of inflammatory responses mediated by NF-κB activation in IA formation and progression and supported the notion that IA is an inflammatory disease affected intracranial arteries. To find out a candidate drug for IA treatments, the effect of several drugs with anti-inflammatory and anti-NF-κB actions on IA progression has been examined using rodent models and revealed the excellent inhibitory effect of statins (HMG-CoA reductase inhibitors) on IA progression. Based on these findings, the case-control study was recently carried out enrolling patients with unruptured or ruptured IAs to examine the effect of statin usage on rupture. This study revealed the significant differences in the ratio of statin usage between two groups and notably the remarkable reduction of risk of rupture of pre-existing IAs under statin usage at the adjusted odds ratio of 0.30. Recent laboratory and clinical studies make considerable achievement toward the future development of drugs for IA treatment and especially suggest the potential of statins as a candidate.
Cite this paper: Tsuji, K. , Aoki, T. , Fukuda, M. and Nozaki, K. (2014) Statins as a Candidate of Drugs for Intracranial Aneurysm Treatment. Health, 6, 1459-1466. doi: 10.4236/health.2014.612180.

[1]   van Gijn, J., Kerr, R.S. and Rinkel, G.J. (2007) Subarachnoid Haemorrhage. Lancet, 369, 306-318.

[2]   Wiebers, D.O., Piepgras, D.G., Brown Jr., R.D., Meissner, I., Torner, J., Kassell, N.F., Whisnant, J.P., Huston 3rd, J. and Nichols, D.A. (2002) Unruptured Aneurysms. Journal of Neurosurgery, 96, 50-51.

[3]   Rinkel, G.J., Djibuti, M., Algra, A. and van Gijn, J. (1998) Prevalence and Risk of Rupture of Intracranial Aneurysms: A Systematic Review. Stroke, 29, 251-256.

[4]   Steiner, T., Juvela, S., Unterberg, A., Jung, C., Forsting, M. and Rinkel, G. (2013) European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage. Cerebrovascular Disease, 35, 93-112.

[5]   Kotowski, M., Naggara, O., Darsaut, T.E., Nolet, S., Gevry, G., Kouznetsov, E. and Raymond, J. (2013) Safety and Occlusion Rates of Surgical Treatment of Unruptured Intracranial Aneurysms: A Systematic Review and Meta-Analysis of the Literature from 1990 to 2011. Journal of Neurology, Neurosurgery, and Psychiatry, 84, 42-48.

[6]   Naggara, O.N., Lecler, A., Oppenheim, C., Meder, J.F. and Raymond, J. (2012) Endovascular Treatment of Intracranial Unruptured Aneurysms: A Systematic Review of the Literature on Safety with Emphasis on Subgroup Analyses. Radiology, 263, 828-835.

[7]   Chyatte, D., Bruno, G., Desai, S. and Todor, D.R. (1999) Inflammation and Intracranial Aneurysms. Neurosurgery, 45, 1137-1146.

[8]   Frosen, J., Piippo, A., Paetau, A., Kangasniemi, M., Niemela, M., Hernesniemi, J. and Jaaskelainen, J. (2004) Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated with Rupture: Histological Analysis of 24 Unruptured and 42 Ruptured Cases. Stroke, 35, 2287-2293.

[9]   Fontanella, M., Rainero, I., Gallone, S., Rubino, E., Fenoglio, P., Valfre, W., Garbossa, D., Carlino, C., Ducati, A. and Pinessi, L. (2007) Tumor Necrosis Factor-Alpha Gene and Cerebral Aneurysms. Neurosurgery, 60, 668-672.

[10]   Jayaraman, T., Berenstein, V., Li, X., Mayer, J., Silane, M., Shin, Y.S., Niimi, Y., Kilic, T., Gunel, M. and Berenstein, A. (2005) Tumor Necrosis Factor Alpha Is a Key Modulator of Inflammation in Cerebral Aneurysms. Neurosurgery, 57, 558-564.

[11]   Kataoka, H. and Aoki, T. (2010) Molecular Basis for the Development of Intracranial Aneurysm. Expert Review of Neurotherapeutics, 10, 173-187.

[12]   Kurki, M.I., Hakkinen, S.K., Frosen, J., Tulamo, R., von und zu Fraunberg, M., Wong, G., Tromp, G., Niemela, M., Hernesniemi, J., Jaaskelainen, J.E. and Yla-Herttuala, S. (2011) Upregulated Signaling Pathways in Ruptured Human Saccular Intracranial Aneurysm Wall: An Emerging Regulative Role of Toll-Like Receptor Signaling and Nuclear Factor-Kappa B, Hypoxia-Inducible Factor-1A, and ETS Transcription Factors. Neurosurgery, 68, 1667-1675.

[13]   Shi, C., Awad, I.A., Jafari, N., Lin, S., Du, P., Hage, Z.A., Shenkar, R., Getch, C.C., Bredel, M., Batjer, H.H. and Bendok, B.R. (2009) Genomics of Human Intracranial Aneurysm Wall. Stroke, 40, 1252-1261.

[14]   Laaksamo, E., Tulamo, R., Baumann, M., Dashti, R., Hernesniemi, J., Juvela, S., Niemela, M. and Laakso, A. (2008) Involvement of Mitogen-Activated Protein Kinase Signaling in Growth and Rupture of Human Intracranial Aneurysms. Stroke, 39, 886-892.

[15]   Laaksamo, E., Tulamo, R., Liiman, A., Baumann, M., Friedlander, R.M., Hernesniemi, J., Kangasniemi, M., Niemela, M., Laakso, A. and Frosen, J. (2013) Oxidative Stress Is Associated with Cell Death, Wall Degradation, and Increased Risk of Rupture of the Intracranial Aneurysm Wall. Neurosurgery, 72, 109-117.

[16]   Krischek, B., Kasuya, H., Tajima, A., Akagawa, H., Sasaki, T., Yoneyama, T., Ujiie, H., Kubo, O., Bonin, M., Takakura, K., Hori, T. and Inoue, I. (2008) Network-Based Gene Expression Analysis of Intracranial Aneurysm Tissue Reveals Role of Antigen Presenting Cells. Neuroscience, 154, 1398-1407.

[17]   Tulamo, R., Frosen, J., Junnikkala, S., Paetau, A., Pitkaniemi, J., Kangasniemi, M., Niemela, M., Jaaskelainen, J., Jokitalo, E., Karatas, A., Hernesniemi, J. and Meri, S. (2006) Complement Activation Associates with Saccular Cerebral Artery Aneurysm Wall Degeneration and Rupture. Neurosurgery, 59, 1069-1076.

[18]   Hashimoto, N., Handa, H. and Hazama, F. (1978) Experimentally Induced Cerebral Aneurysms in Rats. Surgical Neurology, 10, 3-8.

[19]   Aoki, T. and Nishimura, M. (2011) The Development and the Use of Experimental Animal Models to Study the Underlying Mechanisms of CA Formation. Journal of Biomedicine & Biotechnology, 2011, Article ID: 535921.

[20]   Aoki, T., Kataoka, H., Ishibashi, R., Nozaki, K., Egashira, K. and Hashimoto, N. (2009) Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation. Stroke, 40, 942-951.

[21]   Aoki, T., Kataoka, H., Morimoto, M., Nozaki, K. and Hashimoto, N. (2007) Macrophage-Derived Matrix Metalloproteinase-2 and -9 Promote the Progression of Cerebral Aneurysms in Rats. Stroke, 38, 162-169.

[22]   Aoki, T., Kataoka, H., Shimamura, M., Nakagami, H., Wakayama, K., Moriwaki, T., Ishibashi, R., Nozaki, K., Morishita, R. and Hashimoto, N. (2007) NF-κB Is a Key Mediator of Cerebral Aneurysm Formation. Circulation, 116, 2830-2840.

[23]   Aoki, T. and Nishimura, M. (2010) Targeting Chronic Inflammation in Cerebral Aneurysms: Focusing on NF-κB as a Putative Target of Medical Therapy. Expert Opinion on Therapeutic Targets, 14, 265-273.

[24]   Aoki, T., Nishimura, M., Matsuoka, T., Yamamoto, K., Furuyashiki, T., Kataoka, H., Kitaoka, S., Ishibashi, R., Ishibazawa, A., Miyamoto, S., Morishita, R., Ando, J., Hashimoto, N., Nozaki, K. and Narumiya, S. (2011) PGE2-EP2 Signalling in Endothelium Is Activated by Haemodynamic Stress and Induces Cerebral Aneurysm through an Amplifying Loop via NF-κB. British Journal of Pharmacology, 163, 1237-1249.

[25]   Kanematsu, Y., Kanematsu, M., Kurihara, C., Tada, Y., Tsou, T.L., van Rooijen, N., Lawton, M.T., Young, W.L., Liang, E.I., Nuki, Y. and Hashimoto, T. (2011) Critical Roles of Macrophages in the Formation of Intracranial Aneurysm. Stroke, 42, 173-178.

[26]   Fukuda, S., Hashimoto, N., Naritomi, H., Nagata, I., Nozaki, K., Kondo, S., Kurino, M. and Kikuchi, H. (2000) Prevention of Rat Cerebral Aneurysm Formation by Inhibition of Nitric Oxide Synthase. Circulation, 101, 2532-2538.

[27]   Sadamasa, N., Nozaki, K. and Hashimoto, N. (2003) Disruption of Gene for Inducible Nitric Oxide Synthase Reduces Progression of Cerebral Aneurysms. Stroke, 34, 2980-2984.

[28]   Moriwaki, T., Takagi, Y., Sadamasa, N., Aoki, T., Nozaki, K. and Hashimoto, N. (2006) Impaired Progression of Cerebral Aneurysms in Interleukin-1β-Deficient Mice. Stroke, 37, 900-905.

[29]   Dolan, J.M., Kolega, J. and Meng, H. (2013) High Wall Shear Stress and Spatial Gradients in Vascular Pathology: A Review. Annals of Biomedical Engineering, 41, 1411-1427.

[30]   Jou, L.D., Lee, D.H., Morsi, H. and Mawad, M.E. (2008) Wall Shear Stress on Ruptured and Unruptured Intracranial Aneurysms at the Internal Carotid Artery. AJNR. American Journal of Neuroradiology, 29, 1761-1767.

[31]   Takeuchi, S. and Karino, T. (2010) Flow Patterns and Distributions of Fluid Velocity and Wall Shear Stress in the Human Internal Carotid and Middle Cerebral Arteries. World Neurosurgery, 73, 174-185.

[32]   Morishita, R., Tomita, N., Kaneda, Y. and Ogihara, T. (2004) Molecular Therapy to Inhibit NF-κB Activation by Transcription Factor Decoy Oligonucleotides. Current Opinion in Pharmacology, 4, 139-146.

[33]   Bellosta, S., Bernini, F., Ferri, N., Quarato, P., Canavesi, M., Arnaboldi, L., Fumagalli, R., Paoletti, R. and Corsini, A. (1998) Direct Vascular Effects of HMG-CoA Reductase Inhibitors. Atherosclerosis, 137, 101-109.

[34]   Shovman, O., Levy, Y., Gilburd, B. and Shoenfeld, Y. (2002) Antiinflammatory and Immunomodulatory Properties of Statins. Immunologic Research, 25, 271-285.

[35]   Kimura, N., Shimizu, H., Elda-woody, H., Nakayama, T., Saito, A., Tominaga, T. and Takahashi, A. (2010) Effect of Olmesartan and Pravastatin on Experimental Cerebral Aneurysms in Rats. Brain Research, 1322, 144-152.

[36]   Aoki, T., Kataoka, H., Ishibashi, R., Nozaki, K. and Hashimoto, N. (2008) Simvastatin Suppresses the Progression of Experimentally Induced Cerebral Aneurysms in Rats. Stroke, 39, 1276-1285.

[37]   Aoki, T., Kataoka, H., Ishibashi, R., Nakagami, H., Nozaki, K., Morishita, R. and Hashimoto, N. (2009) Pitavastatin Suppresses Formation and Progression of Cerebral Aneurysms through Inhibition of the Nuclear Factor κB Pathway. Neurosurgery, 64, 357-366.

[38]   Tada, Y., Kitazato, K.T., Yagi, K., Shimada, K., Matsushita, N., Kinouchi, T., Kanematsu, Y., Satomi, J., Kageji, T. and Nagahiro, S. (2011) Statins Promote the Growth of Experimentally Induced Cerebral Aneurysms in Estrogen-Deficient Rats. Stroke, 42, 2286-2293.

[39]   Aoki, T., Kataoka, H., Ishibashi, R., Nozaki, K. and Hashimoto, N. (2008) Nifedipine Inhibits the Progression of an Experimentally Induced Cerebral Aneurysm in Rats with Associated Down-Regulation of NF-κB Transcriptional Activity. Current Neurovascular Research, 5, 37-45.

[40]   Ishibashi, R., Aoki, T., Nishimura, M. and Miyamoto, S. (2012) Imidapril Inhibits Cerebral Aneurysm Formation in an Angiotensin-Converting Enzyme-Independent and Matrix Metalloproteinase-9-Dependent Manner. Neurosurgery, 70, 722-730.

[41]   Ishibashi, R., Aoki, T., Nishimura, M., Hashimoto, N. and Miyamoto, S. (2010) Contribution of Mast Cells to Cerebral Aneurysm Formation. Current Neurovascular Research, 7, 113-124.

[42]   Tada, Y., Kitazato, K.T., Tamura, T., Yagi, K., Shimada, K., Kinouchi, T., Satomi, J. and Nagahiro, S. (2009) Role of Mineralocorticoid Receptor on Experimental Cerebral Aneurysms in Rats. Hypertension, 54, 552-557.

[43]   Yagi, K., Tada, Y., Kitazato, K.T., Tamura, T., Satomi, J. and Nagahiro, S. (2010) Ibudilast Inhibits Cerebral Aneurysms by Down-Regulating Inflammation-Related Molecules in the Vascular Wall of Rats. Neurosurgery, 66, 551-559.

[44]   Marbacher, S., Schlappi, J.A., Fung, C., Husler, J., Beck, J. and Raabe, A. (2012) Do Statins Reduce the Risk of Aneurysm Development? A Case-Control Study. Journal of Neurosurgery, 116, 638-642.

[45]   Juvela, S., Poussa, K. and Porras, M. (2001) Factors Affecting Formation and Growth of Intracranial Aneurysms: A Long-Term Follow-Up Study. Stroke, 32, 485-491.

[46]   Kurth, T., Kase, C.S., Berger, K., Schaeffner, E.S., Buring, J.E. and Gaziano, J.M. (2003) Smoking and the Risk of Hemorrhagic Stroke in Men. Stroke, 34, 1151-1155.

[47]   Sandvei, M.S., Romundstad, P.R., Muller, T.B., Vatten, L. and Vik, A. (2009) Risk Factors for Aneurysmal Subarachnoid Hemorrhage in a Prospective Population Study: The HUNT Study in Norway. Stroke, 40, 1958-1962.

[48]   Yoshimura, Y., Murakami, Y., Saitoh, M., Yokoi, T., Aoki, T., Miura, K., Ueshima, H. and Nozaki, K. (2014) Statin Use and Risk of Cerebral Aneurysm Rupture: A Hospital-Based Case-Control Study in Japan. Journal of Stroke and Cerebrovascular Diseases, 23, 343-348.

[49]   Morita, A., Kirino, T., Hashi, K., Aoki, N., Fukuhara, S., Hashimoto, N., Nakayama, T., Sakai, M., Teramoto, A., Tominari, S. and Yoshimoto, T. (2012) The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort. New England Journal of Medicine, 366, 2474-2482.

[50]   Greving, J.P., Wermer, M.J., Brown Jr., R.D., Morita, A., Juvela, S., Yonekura, M., Ishibashi, T., Torner, J.C., Nakayama, T., Rinkel, G.J. and Algra, A. (2014) Development of the PHASES Score for Prediction of Risk of Rupture of Intracranial Aneurysms: A Pooled Analysis of Six Prospective Cohort Studies. Lancet Neurology, 13, 59-66.

[51]   Hasan, D.M., Mahaney, K.B., Brown Jr., R.D., Meissner, I., Piepgras, D.G., Huston, J., Capuano, A.W. and Torner, J.C. (2011) Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture. Stroke, 42, 3156-3162.

[52]   Schouten, O., van Laanen, J.H., Boersma, E., Vidakovic, R., Feringa, H.H., Dunkelgrun, M., Bax, J.J., Koning, J., van Urk, H. and Poldermans, D. (2006) Statins Are Associated with a Reduced Infrarenal Abdominal Aortic Aneurysm Growth. European Journal of Vascular and Endovascular Surgery, 32, 21-26.

[53]   Periard, D., Guessous, I., Mazzolai, L., Haesler, E., Monney, P. and Hayoz, D. (2012) Reduction of Small Infrarenal Abdominal Aortic Aneurysm Expansion Rate by Statins. VASA. Zeitschrift fur Gefasskrankheiten, 41, 35-42.

[54]   Twine, C.P. and Williams, I.M. (2011) Systematic Review and Meta-Analysis of the Effects of Statin Therapy on Abdominal Aortic Aneurysms. British Journal of Surgery, 98, 346-353.

[55]   Takagi, H., Yamamoto, H., Iwata, K., Goto, S. and Umemoto, T. (2012) Effects of Statin Therapy on Abdominal Aortic Aneurysm Growth: A Meta-Analysis and Meta-Regression of Observational Comparative Studies. European Journal of Vascular and Endovascular Surgery, 44, 287-292.